Clinical Trial
The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative
- PMID: 4154825
Item in Clipboard
Clinical Trial
The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative
Curr Ther Res Clin Exp.
1974 Oct.
No abstract available
Similar articles
-
Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.Drugs. 1974;8(1):1-14. doi: 10.2165/00003495-197408010-00001. Drugs. 1974. PMID: 4154834 Review. No abstract available.
-
Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.Am J Phys Med. 1974 Oct;53(5):223-8. Am J Phys Med. 1974. PMID: 4153338 Clinical Trial. No abstract available.
-
Diazepam and benzoctamlne: effects on certain objective parameters of muscular spasticity.Curr Ther Res Clin Exp. 1973 Aug;15(8):521-33. Curr Ther Res Clin Exp. 1973. PMID: 4200526 Clinical Trial. No abstract available.
-
[Experience with clinical use of the drug gammalon in children with cerebral palsy].Zh Nevropatol Psikhiatr Im S S Korsakova. 1974;74(10):1464-8. Zh Nevropatol Psikhiatr Im S S Korsakova. 1974. PMID: 4154691 Russian. No abstract available.
-
Neuropharmacological actions of GABA agonists: predictability for their clinical usefulness.Adv Biochem Psychopharmacol. 1981;29:59-67. Adv Biochem Psychopharmacol. 1981. PMID: 6114626 Review.
Cited by
-
Evidence basis for treatment of spasticity.Curr Neurol Neurosci Rep. 2001 Nov;1(6):501-6. doi: 10.1007/s11910-001-0051-5. Curr Neurol Neurosci Rep. 2001. PMID: 11898562 Review. No abstract available.